Regulatory Information
As a leading pharma excipients manufacturers in India, RanQ Excipients are manufactured under rigorous manufacturing conditions, which include stringent in-process controls and monitoring of critical process parameters to ensure compendial compliance and Excipients with high quality standards and consistent performance.
To maintain quality standards, RanQ has well defined quality procedures and systems in place in compliance with the requirements of the Current Good Manufacturing Practices (cGMP), WHO-GMP, ICH Q7 and IPEC. This ensures that our operating procedures meet the standards of all regulators.
All of RanQ’s products, including Microcrystalline Cellulose, are manufactured in accordance with International Good Manufacturing Practices and comply with widely used official compendiums.:
- United States Pharmacopoeia (USP-NF)
- British Pharmacopoeia (BP)
- European Pharmacopoeia (EP)
- Indian Pharmacopoeia (IP)